These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1087 related articles for article (PubMed ID: 12649187)

  • 1. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
    Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
    Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
    Yang L; Dan HC; Sun M; Liu Q; Sun XM; Feldman RI; Hamilton AD; Polokoff M; Nicosia SV; Herlyn M; Sebti SM; Cheng JQ
    Cancer Res; 2004 Jul; 64(13):4394-9. PubMed ID: 15231645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
    Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
    Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
    Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
    Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
    Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JSI-124 (cucurbitacin I) inhibits Janus kinase-3/signal transducer and activator of transcription-3 signalling, downregulates nucleophosmin-anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK-positive anaplastic large cell lymphoma cells.
    Shi X; Franko B; Frantz C; Amin HM; Lai R
    Br J Haematol; 2006 Oct; 135(1):26-32. PubMed ID: 16939498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
    Shen X; Tian Z; Holtzman MJ; Gao B
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
    Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
    Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes.
    Nunes M; Shi C; Greenberger LM
    Mol Cancer Ther; 2004 Jan; 3(1):21-7. PubMed ID: 14749472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
    Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.
    Xu Q; Briggs J; Park S; Niu G; Kortylewski M; Zhang S; Gritsko T; Turkson J; Kay H; Semenza GL; Cheng JQ; Jove R; Yu H
    Oncogene; 2005 Aug; 24(36):5552-60. PubMed ID: 16007214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.
    Dong Y; Lu B; Zhang X; Zhang J; Lai L; Li D; Wu Y; Song Y; Luo J; Pang X; Yi Z; Liu M
    Carcinogenesis; 2010 Dec; 31(12):2097-104. PubMed ID: 20732905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.
    Nefedova Y; Nagaraj S; Rosenbauer A; Muro-Cacho C; Sebti SM; Gabrilovich DI
    Cancer Res; 2005 Oct; 65(20):9525-35. PubMed ID: 16230418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.
    Zhang Y; Turkson J; Carter-Su C; Smithgall T; Levitzki A; Kraker A; Krolewski JJ; Medveczky P; Jove R
    J Biol Chem; 2000 Aug; 275(32):24935-44. PubMed ID: 10823829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line.
    Murakami Y; Nakano S; Niho Y; Hamasaki N; Izuhara K
    J Cell Physiol; 1998 May; 175(2):220-8. PubMed ID: 9525481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.
    Ishdorj G; Johnston JB; Gibson SB
    BMC Cancer; 2011 Jun; 11():268. PubMed ID: 21702955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells.
    De Vos J; Jourdan M; Tarte K; Jasmin C; Klein B
    Br J Haematol; 2000 Jun; 109(4):823-8. PubMed ID: 10929036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.